id: alcohol_classification_methodology_to_metald_prevalence
name: Alcohol Use Classification Criteria â†’ MetALD Disease Prevalence
from_node:
  node_id: alcohol_classification_methodology
  node_name: Alcohol Use Classification Criteria
to_node:
  node_id: metald_prevalence
  node_name: MetALD Disease Prevalence
direction: positive
category: political
mechanism_pathway:
- 'Step 1: Different clinical algorithms for classifying alcohol exposure lead to
  dramatically different disease category assignments'
- 'Step 2: Varying thresholds and data sources for hazardous alcohol use affect which
  patients are classified as MetALD versus MASLD or ALD'
- 'Step 3: Classification methodology directly determines apparent prevalence of MetALD,
  ranging from 4.7% to 47.2% depending on criteria used'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Catherine Mezzacappa et al. 2025. "Validation and Epidemiologic
    Definition of the Novel Steatotic Liver Disease Nomenclature in a National United
    States Cohort With Cirrhosis.." *Clinical gastroenterology and hepatology : the
    official clinical practice journal of the American Gastroenterological Association*.
    https://doi.org/10.1016/j.cgh.2024.10.035'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.378676'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: alcohol_assessment_method
  direction: strengthens
  strength: strong
  description: Different methods for ascertaining alcohol use (self-report, screening
    tools, ICD codes, biomarkers) produce vastly different classifications and apparent
    disease prevalence
- name: cardiometabolic_risk_weighting
  direction: strengthens
  strength: strong
  description: Emphasis on cardiometabolic criteria versus alcohol criteria shifts
    classification boundaries between MASLD, MetALD, and ALD
